Joan Perello Bestard

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 2 EPO patents. Top assignees: Sanifit Therapeutics S.a., Universitat De Les Illes Balears, Laboratorios Sanifit, S.l.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan Perello Bestard. Retrieved from https://idiyas.com/inventor/joan-perello-bestard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 83.3

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 26(Granted Patents)

Location History:

Inca, ES (2013)
Balears, ES (2018)
Palma de Mallorca, ES (2013 - 2024)

Company Filing History:

5 out of 6

Sanifit Therapeutics S.a.

patents

3 out of 13

Universitat De Les Illes Balears

patents

2 out of 2

Laboratorios Sanifit, S.l.

patents

4. 1 out of 1

Laboratoris Sanifit, S.l.

patent

5. 1 out of 834,570

Other

patents

Years Active: 2013-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12594290 - IP and IP analogs dosage regimens for the treatment of ectopic calcifications (2026-04-07),

2. 12130296 - Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200 (2024-10-29),

3. 12070469 - IP and IP analogs dosage regimens for the treatment of ectopic calcifications (2024-08-27),

4. 11162958 - Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200 (2021-11-02),

5. 10973838 - IP and IP analogs dosage regimens for the treatment of ectopic calcifications (2021-04-13),

6. 10010559 - Use of derivatives containing C-O-P bonds in patients with kidney failure (2018-07-03),

7. 9612250 - Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200 (2017-04-04),

8. 9364490 - Use of derivatives containing C—O—P bonds in patients with kidney failure (2016-06-14),

9. 9155750 - Composition of dialysis liquid comprising crystallisation inhibitor substances (2015-10-13),

10. 8778912 - Composition of dialysis liquid comprising crystallisation inhibitor substances (2014-07-15),

11. 8377909 - Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis (2013-02-19),

12. 8377908 - Fixed-dose association of phytate and zinc (2013-02-19),

Title: Joan Perello Bestard - Innovative Inventor from Palma de Mallorca

Introduction: Joan Perello Bestard is a talented inventor hailing from Palma de Mallorca, Spain, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Joan Perello Bestard holds several patents in the areas of renewable energy technologies, sustainable materials, and smart devices, showcasing her commitment to creating a more eco-friendly and efficient world.

Career Highlights: With a background in engineering and a passion for sustainability, Joan Perello Bestard has worked with leading research institutions and universities to develop cutting-edge solutions for environmental challenges. Her innovative approach has earned her recognition as a pioneer in her field.

Collaborations: Joan Perello Bestard has collaborated with top companies in the renewable energy sector, partnering with like-minded professionals to bring her inventions to the market. Her collaborative spirit and dedication to making a positive impact have led to successful projects that benefit both society and the environment.

Conclusion: Joan Perello Bestard's inventive spirit and dedication to sustainability make her a standout figure in the world of innovation. Her work continues to inspire others to think creatively and push the boundaries of what is possible in technology and environmental conservation.

Profile summary based on public USPTO records.